Advertisement
Screener

MANNATECH INC (MTEX) Operating Lease, Right-of-Use Asset, Amortization Expense

1.2 / 5 stars · 25/107 Roast Me

MANNATECH INC Operating Lease, Right-of-Use Asset, Amortization Expense

MANNATECH INC (MTEX) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $778.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.

Financial Statements › Cash Flow › Operating Activities

us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2026-08-12

  • MANNATECH INC operating lease, right-of-use asset, amortization expense for the quarter ending 2026-06-30 was $383.00K, a 10.51% decline year-over-year.
  • MANNATECH INC operating lease, right-of-use asset, amortization expense for the quarter ending 2026-03-31 was $395.00K, a 2.47% decline year-over-year.
  • MANNATECH INC operating lease, right-of-use asset, amortization expense for the quarter ending 2025-12-31 was $279.00K, a 10.86% decline year-over-year.
  • MANNATECH INC operating lease, right-of-use asset, amortization expense for the quarter ending 2025-09-30 was $460.00K.
  • MANNATECH INC operating lease, right-of-use asset, amortization expense for fiscal 2025 was $1.57M, a 2.01% increase from fiscal 2024.
  • MANNATECH INC operating lease, right-of-use asset, amortization expense for fiscal 2024 was $1.54M.
Period endOperating Lease, Right-of-Use Asset, Amortization Expense 3 monthOperating Lease, Right-of-Use Asset, Amortization Expense 6 monthOperating Lease, Right-of-Use Asset, Amortization Expense 9 monthOperating Lease, Right-of-Use Asset, Amortization Expense 12 month
2026-06-30$383.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12
$778.00K
10-Q · filed 2026-08-12
$1.06M
derived: sum of 3 quarters · filed 2026-08-12
$1.52M
derived: sum of 4 quarters · filed 2026-08-12
2026-03-31$395.00K
10-Q · filed 2026-05-14
$674.00K
derived: sum of 2 quarters · filed 2026-05-14
$1.13M
derived: sum of 3 quarters · filed 2026-05-14
$1.56M
derived: sum of 4 quarters · filed 2026-08-12
2025-12-31$279.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15
$739.00K
derived: sum of 2 quarters · filed 2026-04-15
$1.17M
derived: sum of 3 quarters · filed 2026-08-12
$1.57M
10-K · filed 2026-04-15
2025-09-30$460.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12
$888.00K
derived: sum of 2 quarters · filed 2026-08-12
$1.29M
10-Q · filed 2025-11-12
$1.61M
derived: sum of 4 quarters · filed 2026-08-12
2025-06-30$428.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12
$833.00K
10-Q · filed 2026-08-12
$1.15M
derived: sum of 3 quarters · filed 2026-08-12
2025-03-31$405.00K
10-Q · filed 2026-05-14
$718.00K
derived: sum of 2 quarters · filed 2026-05-14
2024-12-31$313.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15
$1.54M
10-K · filed 2026-04-15
2024-09-30$1.23M
10-Q · filed 2025-11-12

Similar stocks

Stock NameCountryMarket CapPE Ratio
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
Niagen Bioscience, Inc. (NAGE)United States$0.238B15.72
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
Canopy Growth Corp (CGC)$0.395B
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
Cronos Group Inc. (CRON)$1.223B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87